Advertisement

Pharmaceutisch Weekblad

, Volume 14, Issue 6, pp 365–369 | Cite as

Stability and compatibility of four anthracyclines: doxorubicin, epirubicin, daunorubicin and pirarubicin with PVC infusion bags

  • T. Dine
  • J. C. Cazin
  • B. Gressier
  • M. Luyckx
  • C. Brunet
  • M. Cazin
  • F. Goudaliez
  • M. L. Mallevais
  • I. Toraub
Practice/Case Reports

Abstract

A rapid isocratic technique was developed for the analysis of four anthracyclines (doxorubicin, epirubicin, daunorubicin and pirarubicin) in parenteral solutions using high pressure liquid chromatography (HPLC) with fluorescence detection and a C18 Hypersil ODS column. The availability and compatibility of these drugs from solutions infused via PVC infusion bags through PVC administration sets have been examined. No significant drug loss was observed during simulated infusions (n=4) for 24 h using PVC infusion bags and administration sets. No significant difference was found between infusion solutions (5% glucose or 0.9% NaCl), except for pirarubicin. The reconstitution of pirarubicin in 0.9% NaCl was impossible, because we observed a precipitation of the compound in solution. The stability of the drugs was also studied in solution, in PVC bags after storage at 4°C with protection from light. The results show the stability of doxorubicin, epirubicin and daunorubicin during 7 days of storage to be satisfactory, irrespective of the infusion solution (5% glucose or 0.9% NaCl). In the case of pirarubicin, the stability of the drug was satisfactory during 5 days of storage in 5% glucose, but beyond, we observed a degradation of the compound with formation of doxorubicin in the infusion solution.

Keywords

Chromatography, high pressure liquid Compatibility Daunorubicin Doxorubicin Drug stability Epirubicin Infusions Pirarubicin Polyvinyl chloride 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Lavelle F. Structure et activités des anthracyclines. Pathol Biol (Paris) 1987;35:11–9.Google Scholar
  2. 2.
    Greidanus J, Willemse PH, Uges DR, Oremus ET, De Langen ZJ, De Vries EG. Continuous infusion of low-dose doxorubicin, epirubicin and mitoxantrone in cancer chemotherapy: a review. Pharm Weekbl [Sci] 1988;10:237–45.Google Scholar
  3. 3.
    DeVries EG, Nanninga AG, Greidanus J, Oremus ET, Verschueren RC, Mulder NH, et al. A phase II study of a 21 days continuous infusion schedule with epirubicin in advanced gastric cancer. Eur J Cancer Clin Oncol 1989;25:1509–10.CrossRefPubMedGoogle Scholar
  4. 4.
    Speth PA, Linssen PC, Boezeman JB, Wesssels HM, Haanen C. Leukemic cell and plasma daunomycin concentrations after bolus injection and 72 h infusion. Cancer Chemother Pharmacol 1987;20:311–5.PubMedGoogle Scholar
  5. 5.
    Carlson RW, Sikic BI. Continuous infusion or bolus injection in cancer chemotherapy. Ann Intern Med 1983;99:823–3.PubMedGoogle Scholar
  6. 6.
    Paul C, Tidefelt U, Liliemark J, Peterson C. Increasing the accumulation of daunorubicin in human cells by prolonging the infusion time. Leuk Res 1989;13:191–6.CrossRefPubMedGoogle Scholar
  7. 7.
    Greidanus J, Willemse PH, Sleijfer DT, Mulder NH, Verschueren RC, Nieweg R, et al. Phase II study of a 21-day continuous infusion schedule with epirubicin in metastatic colorectal cancer. Eur J Cancer Clin Oncol 1988;24:801–2.CrossRefPubMedGoogle Scholar
  8. 8.
    D'Arcy PF. Drug interactions and reactions update. Drugs Intell Clin Pharm 1983;17:726–31.Google Scholar
  9. 9.
    Moorhatch P, Chiou WL. Interactions between drugs and plastic intravenous fluid bags. Part I: sorption studies on 17 drugs. Am J Hosp Pharm 1974;31:72–8.PubMedGoogle Scholar
  10. 10.
    Benvenuto JA, Anderson RW, Kerkof K, Smith RG, Loo TL. Stability and compatibility of antitumor agents in glass and plastic containers. Am J Hosp Pharm 1981;38:1914–8.PubMedGoogle Scholar
  11. 11.
    Illum L, Bundgaard H. Sorption of drugs by plastic infusion bags. Int J Pharm 1982;10:339–51.CrossRefGoogle Scholar
  12. 12.
    Bots AM, Van Oort WJ, Noordhoek J, Van Dijk A, Klein SW, Van Haesel QG. Analysis of adriamycin and adriamycinol in micro volumes of rat plasma. J Chromatogr 1983;272:421–7.PubMedGoogle Scholar
  13. 13.
    Poochikian GK, Cradock JC, Flora KP. Stability of anthracycline antitumor agents in four infusion fluids. Am J Hosp Pharm 1981;38:483–6.PubMedGoogle Scholar
  14. 14.
    Bosanquet AG. Stability of solutions of antineoplastic agents during preparation and storage forin vitro assays. II. Assay methods, adriamycin and the other antitumor antibiotics. Cancer Chem Pharm 1986;17:1–10.CrossRefGoogle Scholar
  15. 15.
    Robert J, David M, Huet S, Chauvergne J, Monnier A. Pharmacocinétique de la pirarubicine (THP-doxorubicine) chez des malades cancéreux. Bull Cancer 1989;76:889–92.PubMedGoogle Scholar
  16. 16.
    Speth PA, Linssen PC, Boezeman JB, Wessels HM, Haanen C. Cellular and plasma adriamycin concentrations in long-term infusion therapy of leukemia patients. Cancer Chemother Pharm 1987;20:305–10.Google Scholar
  17. 17.
    Ackland SP, Ratain MJ, Vogelzang NJ, Choi KE, Ruane M, Sinkule JA. Pharmacokinetics and pharmacodynamics of long-term continuous-infusion doxorubicin. Clin Pharmacol Ther 1989;45:340–7.PubMedGoogle Scholar
  18. 18.
    Liso V, Specchia G, Pavone V, Capalbo S, Dione R. Continuous infusion chemotherapy with epirubicin and vincristine in relapsed and refractory acute leukemia. Acta Haematol 1990;83:116–9.PubMedGoogle Scholar
  19. 19.
    Kowaluk EA, Roberts MS, Blackburn HP, Polack AE. Interactions between drugs and polyvinyl chloride infusion bags. Am J Hosp Pharm 1981;38:1308–14.PubMedGoogle Scholar
  20. 20.
    Magnam J, Martin JP. Les anticancéreux sont-ils compatibles avec les matières plastiques? Lett QS Cancer 1988;72:1–6.Google Scholar

Copyright information

© Royal Dutch Association for Advancement of Pharmacy 1992

Authors and Affiliations

  • T. Dine
    • 1
  • J. C. Cazin
    • 1
  • B. Gressier
    • 1
  • M. Luyckx
    • 1
  • C. Brunet
    • 1
  • M. Cazin
    • 1
  • F. Goudaliez
    • 2
  • M. L. Mallevais
    • 2
  • I. Toraub
    • 2
  1. 1.Laboratoire de PharmacologiePharmacocinétique et Pharmacie Clinique, Faculté des Sciences Pharmaceutiques et BiologiquesLille CédexFrance
  2. 2.Laboratoires MacopharmaTourcoing CédexFrance

Personalised recommendations